María Teresa Diz-Lois Palomares

4PUBLICATIONS
87CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 12, 2026
Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.

|Sep 29, 2025
Effectiveness and safety of dual advanced therapy in inflammatory bowel disease: a multicenter series from Galicia, Spain.

M ª Teresa Diz-Lois Palomares, Carmen Pradera Cibreiro, Carmen Cabezal Iglesias

|Jan 02, 2025
Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Antonio Giordano, Isabel Pérez-Martínez, Javier P Gisbert

|Feb 16, 2022
Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week.

M ª Teresa Diz-Lois Palomares, Ángeles Porta Sánchez, Laida Elberdin Pazos

Pageof 1

Frequent Collaborators

2 joint publications

Francisco Mesonero

2 joint publications

Margalida Calafat

2 joint publications

Rufo Lorente

2 joint publications

Pilar Nos